{"transactions":[{"id":941893,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69636,"kind":"person","name":"Kalin Katherine Bach","position":1,"cik":"0001832671","reported_name":"Kalin Katherine Bach","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-09T21:31:37.000Z","date":"2026-01-07","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 50,000 restricted stock units on January 7, 2026, which shall vest in full on December 1, 2026, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":154400,"source":{"system":"sec-edgar","filing":"0001104659-26-002499","document":"tm262627-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465926002499/tm262627-2_4seq1.xml","form_type":"4"}},{"id":991104,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69636,"kind":"person","name":"Kalin Katherine Bach","position":1,"cik":"0001832671","reported_name":"Kalin Katherine Bach","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-21T13:45:10.000Z","date":"2025-11-19","kind":"purchase","planned":false,"acquired":true,"shares":63400,"price":1.59,"value":100806.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reflects the weighted average purchase price of the shares of common stock purchased. These shares of common stock were purchased in multiple transactions at prices ranging from $1.555 to $1.625 per share. Ms. Kalin undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of common stock purchased at each price."}],"balance_after":104400,"source":{"system":"sec-edgar","filing":"0001104659-25-114806","document":"tm2531880-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465925114806/tm2531880-1_4seq1.xml","form_type":"4"}},{"id":1136751,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69636,"kind":"person","name":"Kalin Katherine Bach","position":1,"cik":"0001832671","reported_name":"Kalin Katherine Bach","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-22T20:05:17.000Z","date":"2025-05-22","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":1.8,"value":36000.0,"ownership":{"direct":true},"balance_after":41000,"source":{"system":"sec-edgar","filing":"0001104659-25-051980","document":"tm2515989-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465925051980/tm2515989-1_4seq1.xml","form_type":"4"}},{"id":1303222,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69636,"kind":"person","name":"Kalin Katherine Bach","position":1,"cik":"0001832671","reported_name":"Kalin Katherine Bach","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-14T22:31:54.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":18500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will fully vest on the earlier of (x) January 10, 2026 (the first anniversary of the date of grant) or (y) the business day prior to the 2026 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":18500,"derivative":{"exercise_price":0.9525,"expiration_date":"2035-01-10","underlying":"Common Stock","underlying_shares":18500},"source":{"system":"sec-edgar","filing":"0001104659-25-003496","document":"tm253166-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465925003496/tm253166-3_4seq1.xml","form_type":"4"}},{"id":1303221,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69636,"kind":"person","name":"Kalin Katherine Bach","position":1,"cik":"0001832671","reported_name":"Kalin Katherine Bach","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-14T22:31:54.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 12,500 restricted stock units on January 10, 2025, which shall vest in full on December 1, 2025, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":21000,"source":{"system":"sec-edgar","filing":"0001104659-25-003496","document":"tm253166-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465925003496/tm253166-3_4seq1.xml","form_type":"4"}},{"id":1670715,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69636,"kind":"person","name":"Kalin Katherine Bach","position":1,"cik":"0001832671","reported_name":"Kalin Katherine Bach","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-25T11:03:06.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will fully vest on the earlier of (x) January 22, 2025 (the first anniversary of the date of grant) or (y) the business day prior to the 2025 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":10000,"derivative":{"exercise_price":0.5195,"expiration_date":"2034-01-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-24-006401","document":"tm243935-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465924006401/tm243935-3_4seq1.xml","form_type":"4"}},{"id":1670714,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69636,"kind":"person","name":"Kalin Katherine Bach","position":1,"cik":"0001832671","reported_name":"Kalin Katherine Bach","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-25T11:03:06.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 6,000 restricted stock units on January 22, 2024, which shall vest in full on December 1, 2024, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":8500,"source":{"system":"sec-edgar","filing":"0001104659-24-006401","document":"tm243935-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465924006401/tm243935-3_4seq1.xml","form_type":"4"}},{"id":2032343,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69636,"kind":"person","name":"Kalin Katherine Bach","position":1,"cik":"0001832671","reported_name":"Kalin Katherine Bach","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-03T22:10:08.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will fully vest on the earlier of (x) February 2, 2024 (the first anniversary of the date of grant) or (y) the business day prior to the 2024 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":9500,"derivative":{"exercise_price":3.34,"expiration_date":"2033-02-02","underlying":"Common Stock","underlying_shares":9500},"source":{"system":"sec-edgar","filing":"0001104659-23-010613","document":"tm235353d1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465923010613/tm235353d1_4seq1.xml","form_type":"4"}},{"id":2032342,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69636,"kind":"person","name":"Kalin Katherine Bach","position":1,"cik":"0001832671","reported_name":"Kalin Katherine Bach","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-03T22:10:08.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 2,500 restricted stock units on February 2, 2023, which shall vest in full on December 1, 2023, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001104659-23-010613","document":"tm235353d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465923010613/tm235353d1_4seq1.xml","form_type":"4"}},{"id":2183747,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69636,"kind":"person","name":"Kalin Katherine Bach","position":1,"cik":"0001832671","reported_name":"Kalin Katherine Bach","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-16T20:08:20.000Z","date":"2022-08-13","kind":"grant","acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will fully vest on August 13, 2023."}],"balance_after":19000,"derivative":{"exercise_price":3.1,"expiration_date":"2032-08-13","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001104659-22-091751","document":"tm2223585-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465922091751/tm2223585-1_4seq1.xml","form_type":"4"}},{"id":2667831,"issuer":{"id":95922,"kind":"organization","name":"ATHERSYS, INC / NEW","symbol":"ATHX"},"owners":[{"id":69636,"kind":"person","name":"Kalin Katherine Bach","position":1,"cik":"0001832671","reported_name":"Kalin Katherine Bach","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"NonQualified Stock Option (right to purchase)","published_at":"2021-06-15T17:56:49.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Award of a nonqualified stock option. The option vests ratably on a quarterly basis over a one-year period."}],"balance_after":50000,"derivative":{"exercise_price":1.54,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001368148-21-000078","document":"wf-form4_162379417108409.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368148/000136814821000078/wf-form4_162379417108409.xml","form_type":"4"}},{"id":2977126,"issuer":{"id":95922,"kind":"organization","name":"ATHERSYS, INC / NEW","symbol":"ATHX"},"owners":[{"id":69636,"kind":"person","name":"Kalin Katherine Bach","position":1,"cik":"0001832671","reported_name":"Kalin Katherine Bach","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"NonQualified Stock Option (right to purchase)","published_at":"2020-11-17T16:15:48.000Z","date":"2020-11-12","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Award of a nonqualified stock option. The option vests one-third on the one-year anniversary date from the date of grant, and the remainder vests on a quarterly basis over years two and three."}],"balance_after":100000,"derivative":{"exercise_price":1.88,"expiration_date":"2030-11-12","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001368148-20-000137","document":"wf-form4_160564773588881.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368148/000136814820000137/wf-form4_160564773588881.xml","form_type":"4"}}]}